Novak Djokovic co-owns major bio-tech company in Serbia reveals company's CEO

The tennis sensation Novak Djokovic, who recently lost his chance to fetch his 21st grand slam due to his vaccination status, is revealed to hold major stakes in a firm that works to develop Covid-19 drugs.

The tennis sensation Novak Djokovic recently lost his chance to fetch his 21st grand slam due to his vaccination status. He is revealed to hold major stakes in a firm that works to develop Covid-19 drugs.

In the Danish company's CEO, Ivan Loncarevic's words "He is one of the founders of my company. We founded in June 2020. We aim to develop a new technology to fight viruses and resistant bacteria and we decided to use Covid as a showcase."

He further ended his statement by saying "If we succeed with Covid, we will succeed with other viruses."

As the reports suggest, Novak Djokovic, 34, and his wife, Jelena, own 80% of QuantBioRes. It employs approximately 20 people in Denmark, Slovenia, Australia, and the United Kingdom.

However, neither Djokovic, nor his wife had anything to comment regarding this.

Read also : Australian open 2022:Australia government doesn't allow Djokovic to participate